BBLG

Bone Biologics
BBLG

7 hedge funds and large institutions have $74.1K invested in Bone Biologics in 2025 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$25K
2
+$22.1K
3
+$21.6K
4
TRCT
Tower Research Capital (TRC)
New York
+$3.82K
5
UBS Group
UBS Group
Switzerland
+$3.75K

Top Sellers

1
-$575
2
-$385
Name Holding Trade Value Shares
Change 		Change in
Stake
DS
1
DRW Securities
Illinois
$34.2K
Two Sigma Investments
2
Two Sigma Investments
New York
$16.1K
Citadel Advisors
3
Citadel Advisors
Florida
$15.7K
TRCT
4
Tower Research Capital (TRC)
New York
$4.9K
UBS Group
5
UBS Group
Switzerland
$2.83K
SS
6
SBI Securities
Japan
$334
Bank of America
7
Bank of America
North Carolina
$20
Citigroup
8
Citigroup
New York
–
CS
9
Clear Street
New York
–